Krystal Biotech (KRYS) Capital Expenditures Growth (1y) (2017 - 2026)
Krystal Biotech (KRYS) Capital Expenditures Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -27.93% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 15.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.22% |
| Dec 31, 2025 | -51.70% |
| Sep 30, 2025 | 86.24% |
| Jun 30, 2025 | -166.71% |
| Mar 31, 2025 | 392.38% |
| Dec 31, 2024 | -40.85% |
| Sep 30, 2024 | 36.83% |
| Jun 30, 2024 | 297.83% |
| Mar 31, 2024 | -89.38% |
| Dec 31, 2023 | -42.58% |
| Sep 30, 2023 | 63.41% |
| Jun 30, 2023 | -116.61% |
| Mar 31, 2023 | 131,933.33% |
| Dec 31, 2022 | 163.99% |
| Sep 30, 2022 | -232.55% |
| Jun 30, 2022 | 478.19% |
| Mar 31, 2022 | -100.34% |
| Dec 31, 2021 | -1,229.45% |
| Sep 30, 2021 | 300.55% |
| Jun 30, 2021 | 78.76% |